Compare SUVEN LIFE with FDC LTD. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFESCIENCES vs FDC LTD. - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFESCIENCES FDC LTD. SUVEN LIFESCIENCES/
FDC LTD.
 
P/E (TTM) x 19.4 17.5 111.0% View Chart
P/BV x 3.9 2.4 166.1% View Chart
Dividend Yield % 0.5 0.0 -  

Financials

 SUVEN LIFESCIENCES   FDC LTD.
EQUITY SHARE DATA
    SUVEN LIFESCIENCES
Mar-19
FDC LTD.
Mar-18
SUVEN LIFESCIENCES/
FDC LTD.
5-Yr Chart
Click to enlarge
High Rs338319 105.9%   
Low Rs169164 103.3%   
Sales per share (Unadj.) Rs52.161.6 84.6%  
Earnings per share (Unadj.) Rs6.89.9 68.7%  
Cash flow per share (Unadj.) Rs8.612.0 71.6%  
Dividends per share (Unadj.) Rs1.500-  
Dividend yield (eoy) %0.60-  
Book value per share (Unadj.) Rs65.373.2 89.2%  
Shares outstanding (eoy) m127.28174.40 73.0%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x4.93.9 124.2%   
Avg P/E ratio x37.124.3 152.9%  
P/CF ratio (eoy) x29.620.2 146.6%  
Price / Book Value ratio x3.93.3 117.7%  
Dividend payout %22.00-   
Avg Mkt Cap Rs m32,27242,118 76.6%   
No. of employees `0001.15.5 19.6%   
Total wages/salary Rs m6612,167 30.5%   
Avg. sales/employee Rs Th6,132.21,943.7 315.5%   
Avg. wages/employee Rs Th611.1391.7 156.0%   
Avg. net profit/employee Rs Th803.5313.7 256.1%   
INCOME DATA
Net Sales Rs m6,63510,751 61.7%  
Other income Rs m242510 47.5%   
Total revenues Rs m6,87711,260 61.1%   
Gross profit Rs m1,6042,267 70.8%  
Depreciation Rs m221351 63.0%   
Interest Rs m3814 269.3%   
Profit before tax Rs m1,5872,411 65.8%   
Minority Interest Rs m0-5 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m718671 107.0%   
Profit after tax Rs m8691,735 50.1%  
Gross profit margin %24.221.1 114.7%  
Effective tax rate %45.227.8 162.5%   
Net profit margin %13.116.1 81.2%  
BALANCE SHEET DATA
Current assets Rs m6,2327,213 86.4%   
Current liabilities Rs m1,4902,104 70.8%   
Net working cap to sales %71.547.5 150.4%  
Current ratio x4.23.4 122.0%  
Inventory Days Days8654 158.6%  
Debtors Days Days8328 297.9%  
Net fixed assets Rs m4,0436,865 58.9%   
Share capital Rs m127175 72.7%   
"Free" reserves Rs m8,18312,586 65.0%   
Net worth Rs m8,31012,761 65.1%   
Long term debt Rs m186 296.7%   
Total assets Rs m10,38915,041 69.1%  
Interest coverage x43.1173.2 24.9%   
Debt to equity ratio x00 455.6%  
Sales to assets ratio x0.60.7 89.4%   
Return on assets %8.711.6 75.1%  
Return on equity %10.513.6 76.9%  
Return on capital %19.519.0 102.9%  
Exports to sales %012.3 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA1,327 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m5,6221,889 297.6%   
Fx outflow Rs m1,7990-   
Net fx Rs m3,8221,889 202.4%   
CASH FLOW
From Operations Rs m3561,498 23.7%  
From Investments Rs m-279201 -138.5%  
From Financial Activity Rs m-225-1,694 13.3%  
Net Cashflow Rs m-14810 -1,438.8%  

Share Holding

Indian Promoters % 63.4 68.9 92.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 4.7 -  
FIIs % 0.0 7.5 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 19.0 192.1%  
Shareholders   37,287 23,730 157.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFESCIENCES With:   ALKEM LABORATORIES  PLETHICO PHARMA  GLENMARK PHARMA  TORRENT PHARMA  FRESENIUS KABI ONCO.  

Compare SUVEN LIFESCIENCES With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex's Journey From 640 Points Down to 2,000 Points Up(Podcast)

What a week it was! While crude oil prices dragged the Indian stock markets lower, finance minister Nirmala Sitharaman's boosters sent markets soaring and how!

Related Views on News

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

FDC LTD. Announces Quarterly Results (1QFY20); Net Profit Up 2.4% (Quarterly Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

For the quarter ended June 2019, FDC LTD. has posted a net profit of Rs 523 m (up 2.4% YoY). Sales on the other hand came in at Rs 3 bn (up 17.9% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

FDC LTD. Announces Quarterly Results (4QFY19); Net Profit Up 6.8% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, FDC LTD. has posted a net profit of Rs 337 m (up 6.8% YoY). Sales on the other hand came in at Rs 3 bn (down 0.6% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

SUVEN LIFESCIENCES Announces Quarterly Results (4QFY19); Net Profit Up 8.7% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 680 m (up 8.7% YoY). Sales on the other hand came in at Rs 3 bn (up 18.5% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

The 5 Best Trading Opportunities I've Spotted(Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFESCIENCES SHARE PRICE


Sep 20, 2019 (Close)

TRACK SUVEN LIFESCIENCES

  • Track your investment in SUVEN LIFESCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN LIFESCIENCES

SUVEN LIFESCIENCES 8-QTR ANALYSIS

COMPARE SUVEN LIFESCIENCES WITH

MARKET STATS